Zoetis, a company involved in animal health, opened its monoclonal antibodies (mAbs) expansion in Lincoln, NE. The new facility will increase production of products that control osteoarthritis pain in dogs and cats, the company’s largest growing area of need for pet care customers. The location will also be a home for future innovation and serve as a veterinary medicine R&D registration facility for the company as it looks to expand its portfolio with future innovations. “We are excited t...